Phase I assessment of safety and therapeutic activity of BAY1436032 in patients with IDH1-mutant solid tumors - Wick, Antje; Bähr, Oliver; Schuler, Martin; Rohrberg, Kristoffer; Chawla, Sant P.; Janku, Filip; Schiff, David; Heinemann, Volker; Narita, Yoshitaka; Lenz, Heinz-Josef; Ikeda, Masafumi; Ando, Yuichi; et al. (Clinical cancer research, 2021)
Gesehen am 21.02.2022